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OBJECTIVEdBoth stressful intrauterine milieus and genetic susceptibility have been linked
to later-life diabetes risk. The current study aims to examine the interaction between low birth
weight, a surrogate measure of stressful intrauterine milieus, and genetic susceptibility in relation
to risk of type 2 diabetes in adulthood.
RESEARCH DESIGN AND METHODSdThe analysis included two independent,
nested case-control studies of 2,591 type 2 diabetic case subjects and 3,052 healthy control
subjects. We developed two genotype scores: an obesity genotype score based on 32 BMI-
predisposing variants and a diabetes genotype score based on 35 diabetes-predisposing variants.
RESULTSdObesity genotype scores showed a stronger association with type 2 diabetes risk in
individuals with low birth weight. In low–birth weight individuals, the multivariable-adjusted
odds ratio (OR) was 2.55 (95% CI 1.34–4.84) by comparing extreme quartiles of the obesity
genotype score, while theORwas 1.27 (1.04–1.55) among individuals with birth weight.2.5 kg
(P for interaction = 0.017). We did not observe signiﬁcant interaction between diabetes genotype
scores and birth weight with regard to risk of type 2 diabetes. In a comparison of extreme
quartiles of the diabetes gene score, the multivariable-adjusted OR was 3.80 (1.76–8.24) among
individuals with low birth weight and 2.27 (1.82–2.83) among those with high birth weight
(P for interaction = 0.16).
CONCLUSIONSdOur data suggest that low birth weight and genetic susceptibility to obe-
sity may synergistically affect adulthood risk of type 2 diabetes.
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Accumulating evidence has shownthat the risk of type 2 diabetes inlater life might be programmed by
intrauterine exposure to environmental
stress such as malnutrition (1,2), which
may cause physiological, epigenetic, or
structural alterations related to poor de-
velopment of pancreatic b-cell mass and
function (3) or insulin resistance (4) in the
offspring and subsequently increase the
susceptibility to risk of type 2 diabetes
during adulthood (1,2). Low birth
weight, as a surrogate for prenatal malnu-
trition, is common in both developing
and developed countries, with prevalence
reaching 8% in the U.S. and 15.5%
worldwide (5). In epidemiology studies,
low birth weight has consistently been re-
lated to increased diabetes risk (6–8).
Recent large-scale genome-wide asso-
ciation studies conﬁrm that common var-
iants in the human genome also contribute
to the development of type 2 diabetes
(9,10). Thus far, nearly 40 loci have been
related to diabetes risk at the genome-wide
signiﬁcance level. In addition, genetic var-
iants predisposing to obesity (11), the most
important risk factor for type 2 diabetes,
have also been found to be related to dia-
betes risk (12). These genetic variants may
affect disease risk through inﬂuencing ei-
ther b-cell function or insulin resistance.
Interestingly, only a few diabetes
(13,14) or obesity (15) loci are directly re-
lated to birth weight and with quite com-
plex effects: some type 2 diabetes risk alleles
are associated with reduced (13) while
some others with increased (14) birth
weight. Those results suggest that the ge-
netic variants and birth weight may affect
the disease risk through different mecha-
nisms. However, the pathways linking low
birth weight or genetic variants to diabetes
are interwoven. Therefore, we assume that
these two types of risk factors may interact
in determining risk of type 2 diabetes.
In this study, we assessed the poten-
tial interaction between birth weight and
genetic susceptibility to type 2 diabetes
and obesity on risk of type 2 diabetes in
two independent prospective cohorts: the
Nurses’ Health Study (NHS) and the
Health Professionals Follow-up Study
(HPFS). The genetic susceptibility was
evaluated by combining all the identiﬁed
common variants from recent genome-
wide association studies.
RESEARCH DESIGN AND
METHODSdThe NHS was initiated in
1976, when 121,700 female registered
nurses aged30–55years completed amailed
questionnaire. Since 1976, information on
disease status and lifestyle factors had been
collected from this cohort every 2 years. The
HPFS was a prospective cohort study of
51,529 U.S. male health professionals aged
40–75 years at study initiation in 1986.
Similarly, information about health and
disease was assessed biennially with self-
administered questionnaires. Bloodwas col-
lected from 32,826 NHS members between
1989 and 1990 and from 18,159 HPFS
members between 1993 and 1999 (16,17).
Participants for the current study were
selected from individuals who provided
blood samples using a nested case-control
study design (18,19). A total of 3,221
(1,467 case and 1,754 control) women and
2,422 men (1,124 case and 1,298 control)
of European ancestry were included in the
current analysis (18,19). All participants
provided written informed consent, and
the study was approved by the Human Re-
search Committee at the Brigham and
Women’s Hospital and Harvard School
of Public Health.
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Type 2 diabetes cases were deﬁned as
self-reported diabetes conﬁrmed by a val-
idated supplementary questionnaire
(20,21). For cases before 1998, we used
the National Diabetes Data Group criteria
to deﬁne type 2 diabetes (22). We used
the American Diabetes Association diag-
nostic criteria for type 2 diabetes diagno-
sis from 1998 onward (23). Control
subjects were deﬁned as those free of di-
abetes at the time of diagnosis for case
subjects and remaining unaffected
through follow-up (until 2006). We
matched the case subjects to nondiabetic
control subjects on age, month and year
of blood draw, and fasting status in NHS
and HPFS, respectively. The validity of
self-reported type 2 diabetes diagnosis
has previously been documented in the
NHS. In a random sample of 62 cases
that were conﬁrmed by the supplemen-
tary questionnaire, 61 cases (98%) were
reconﬁrmed after the subjects’medical re-
cords were reviewed by an endocrinolo-
gist blinded to the supplementary
questionnaire (21). We conducted a sim-
ilar validation study in the HPFS: of 59
type 2 diabetes case subjects who report-
ed newly diagnosed diabetes between
1996 and 1998, 57 (97%) were recon-
ﬁrmed by medical records (20). More-
over, we conducted another substudy to
assess the speciﬁcity of self-reported dia-
betes status. In a random sample of par-
ticipants (n = 200) who reported no
diabetes, only one participant (0.5%)
had an elevated fasting plasma glucose
or plasma fructosamine concentration in
the diabetic range, and her concentrations
were barely above the diagnostic cutoffs
(20,24).
Assessment of birth weight
Participants in NHS (16) and HPFS (17)
cohorts were requested to provide their
birth weight on the 1992 and the 1994
questionnaires, respectively. The actual
birth weights of 220 randomly selected
participants were obtained from state birth
records for validation (25). The Spearman
correlation between self-reported and re-
corded birth weight was 0.74 (P, 0.001).
In addition, 70% of the participants
reported the same birth weight category
as was obtained from state birth records.
We classiﬁed the participants with birth
weight #2.5 kg (5.5 lb) as having low
birth weight (25).
Among the 5,643 participants, 1,689
did not report their birth weight and were
excluded from the analysis regarding low
birth weight. The proportion of people
with birth weight data was comparable
between the diabetic and the control
groups (69.8 vs. 70.3%, respectively;
P = 0.7). Participants who did not recall
their birth weight were more elderly. No
other characteristics were different be-
tween the participants with and without
their birth weight information.
Assessment of covariates
Information about anthropometric data,
smoking status, alcohol intake, meno-
pausal status, postmenopausal hormone
therapy (women only), and family history
of diabetes was derived from the baseline
questionnaires (16). We calculated BMI
as weight in kilograms divided by the
square of height in meters. Physical
activity was expressed as METs per week
using reported time spent on various
activitiesdweighting each activity by its
intensity leveldin 1986 questionnaires
for men and women. The validity of the
self-reported body weight and physical
activity data has previously been de-
scribed (26–28).
Genotyping and imputation
DNA was extracted from the buffy coat
fraction of centrifuged blood using a com-
mercially available kit (QIAmp Blood kit;
Qiagen, Chatsworth, CA). We selected 32
established BMI-predisposing single nu-
cleotide polymorphisms (SNPs) (Supple-
mentary Table 1) and 35 established
diabetes-predisposing SNPs (Supplemen-
tary Table 2). SNP genotyping and impu-
tation have previously been described
in detail (18,19). Brieﬂy, samples were
genotyped and analyzed using the
Affymetrix Genome-Wide Human 6.0 ar-
ray (Affymetrix; Santa Clara, CA) and the
Birdseed calling algorithm. We used
MACH (http://www.sph.umich.edu/csg/
abecasis/MACH) to impute SNPs on chro-
mosomes 1–22 with NCBI build 36 of
Phase II HapMap CEU data (release 22)
as the reference panel.
Genotype score computation
The obesity and diabetes genotype scores
were calculated, respectively, on the basis
of the 32 and 35 SNPs by using a pre-
viously described weighted method (19).
We assumed that each SNP in the panel
acts independently in an additivemanner.
Each SNP was weighted by b-coefﬁcients
obtained from published meta-analyses
(9,11). (The original b value can be found
in the references listed in Supplementary
Tables 1 and 2.) The genotype score
was calculated by multiplying each
b-coefﬁcient by the number of corre-
sponding risk alleles (best estimated
number of alleles for imputed SNPs) and
summing up the products. Because this
produced a score out of 8.78 for obesity
genotype score and 7.49 for diabetes ge-
notype score (twice the sum of the b-
coefﬁcients), all values were divided by
8.78 (or 7.49) and multiplied by 32 (or
35) to make the genetic score easier to in-
terpret. Most of the SNPs included in the
genetic score were genotyped or had a
high imputation quality score (MACH
r2$ 0.8) (Supplementary Tables 1 and 2).
Statistical analyses
x2 tests and t tests were used for compari-
son of proportions and means between
case and control subjects for baseline char-
acteristics. We used logistic regression to
estimate the odds ratio (OR) for risk of
type 2 diabetes, adjusting for age, smoking
(never, past, or current), alcohol intake
(0, 0.1–4.9, 5.0–9.9, 10.0–14.9, or
$15.0 g/day), menopausal status (pre- or
postmenopausal [never, past, or current
menopausal hormone use] [women
only]), and physical activity (quintiles). Be-
cause the results were similar betweenmen
andwomen, similar analyses were repeated
after pooling individual-level data from the
two cohorts and further adjusting for sex.
To examine the accumulative effects of the
genotype scores, we compared the type 2
diabetes risk across the quartiles of the ge-
notype scores according to their distribu-
tion in the study samples. To test for linear
trends across quartiles of genotype score,
we modeled the quartile medians as a con-
tinuous variable. We also performed the
linear relation analysis between the geno-
type scores (as continuous variables) and
risk of type 2 diabetes by using a restricted
cubic spline regression model (29). We
tested the interaction by comparing the
log likelihood of themodel including inter-
action term with the model that contained
only the main effects.
To test the joint effect of the obesity
genotype score and diabetes genotype
score, we divided the sample into high
and low genotype score based on the
median value in control subjects and then
classiﬁed participates into four subgroups
according to the joint classiﬁcation of
obesity genotype score and diabetes ge-
notype score: both low, only with high
obesity genotype score, only with high
diabetes genotype score, and both
high. We then examined the association
between the joint genotype score and
type 2 diabetes stratiﬁed by birth weight.
2480 DIABETES CARE, VOLUME 35, DECEMBER 2012 care.diabetesjournals.org
Birth weight, genes, and diabetes
We did a sensitivity analysis after
excluding the individuals with birth
weight.4.5 kg. Another sensitivity anal-
ysis only included the SNPs that were
genotyped or had a high imputation qual-
ity score (MACH r2$ 0.8). We consid-
ered two-sided P values ,0.05 to be
statistically signiﬁcant. Adjustments for
multiple comparison tests were not per-
formed because SNPs were selected on
the basis of a priori hypothesis. Statistical
analyses were performed in SAS 9.1 (SAS
Institute, Cary, NC).
RESULTSdBaseline characteristics of
case and control subjects in the NHS
(women) and HPFS (men) are shown in
Table 1. In both men and women, type 2
diabetic patients had signiﬁcantly higher
BMI, engaged in less physical activity,
weremore likely to smoke, andmore likely
had a family history of diabetes compared
with control subjects. Women with type 2
diabetes consumed less alcohol and were
more likely to be postmenopausal than
their counterparts in the control group.
The OR for type 2 diabetes associated
with a one-point increase of the obesity
genotype score, corresponding to one
BMI-increasing allele and was 1.03 (95%
CI 1.01–1.05) in men, 1.03 (1.02–1.05)
in women after adjustment for age (Table
2). The age-adjustedOR of type 2 diabetes
associated with each additional diabetes
genotype score was 1.10 (1.08–1.12) in
men and 1.06 (1.04–1.08) in women. The
linear relation analysis indicated that the
genotype scores were linearly related to
elevated type 2 diabetes risk (P for linear-
ity = 0.001 for obesity genotype score and
,0.0001 for diabetes genotype score).
Further adjustment for physical activity,
smoking, alcohol drinking, menopausal
status (women only), and family history
of diabetes did not materially change the
associations of the obesity and diabetes
genotype scores and type 2 diabetes
risk. Further adjustment for BMI abol-
ished the association between the obesity
genotype score and type 2 diabetes but
did not signiﬁcantly change the associa-
tion for diabetes genotype score.
We then analyzed the interaction
between birth weight and the genetic
risk scores for obesity or diabetes in
relation to risk of type 2 diabetes. Because
the results were highly consistent in men
and women, data from the two cohorts
were pooled together (Table 3). We ob-
served signiﬁcant interaction between
birth weight (low versus high; deﬁned
by 2.5 kg) and the obesity genotype score
with regard to risk of diabetes, adjusting
for age and other covariates (P for inter-
action = 0.017). In participants with low
birth weight, the OR was 2.55 (95% CI
1.34–4.84) comparing the highest quar-
tile of obesity genotype score with the
lowest quartile. In participants with high
birth weight, the OR was 1.27 (1.04–
1.55) comparing these two extreme
quartiles. Further adjustment for BMI at-
tenuated the associations among low–
birth weight individuals (OR 1.93
[0.95–3.83] comparing the two extreme
quartiles, P for trend = 0.04) and abol-
ished the association among individuals
with high birth weight (1.0 [0.8–1.23],
P for trend = 0.8; P for interaction = 0.06).
We did not observe signiﬁcant in-
teraction between diabetes genotype
score and birth weight with regard to
type 2 diabetes risk (Table 3). Comparing
individuals of the top with those of the bot-
tom quartile of the diabetes genotype score
yielded the following: the multivariable-
adjusted OR was 3.80 (95% CI 1.76–
8.24) among low–birth weight individuals
and 2.27 (1.82–2.83) among individuals
with birth weight .2.5 kg. However, test
for interaction was marginal (P for inter-
action = 0.16). Further adjustment of the
family history of diabetes did not change
the results materially. We then examined
the joint effects of low birth weight and the
genotype scores on type 2 diabetes risk
(Supplementary Fig. 1). Individuals with
both low birth weight and the top quartile
of genotype score had the highest odds of
type 2 diabetes.
We also performed birth weight–
stratiﬁed analysis for the combined genotype
score of obesity and diabetes (Table 4).
Among individuals with low birth weight,
the multivariate-adjusted OR of type 2 di-
abetes were 3.32 (95% CI 1.17–6.61) for
those only with high obesity genotype
score, 3.16 (1.58–6.33) for those only
with high diabetes genotype score, and
4.7 (2.34–9.45) for those with both high
scores compared with those with both low
scores. Among the individuals with high
birth weight, the corresponding ORs were
1.15 (0.94–1.42), 1.42 (1.17–1.74), and
1.72 (1.41–2.1), respectively (P for inter-
action = 0.05).
We did sensitivity analyses by ex-
cluding individuals whose birth weight
was.4.5 kg or by excluding SNPs with a
low imputation quality score (MACH r2,
0.8). The results were not materially
changed.
CONCLUSIONSdIn two nested case-
control studies from prospective cohorts
of men and women, we observed consis-
tent associations of obesity genotype
score and diabetes genotype score with
risk of type 2 diabetes. We observed
signiﬁcant interaction between birth
weight and obesity genotype score in
predicting diabetes, and the genetic ef-
fects were more pronounced in low–birth
weight individuals than in those with
high birth weight.
The association between genetic sus-
ceptibility and risk of type 2 diabetes pre-
sented in our study was in line with the
Table 1dCharacteristics of type 2 diabetes case and control subjects at baseline
Men Women
Case
subjects
Control
subjects P
Case
subjects
Control
subjects P
n 1,124 1,298 1,467 1,754
Age (years) 55.1 6 8.6 55.0 6 8.4 0.65 43.5 6 6.7 43.1 6 6.8 0.08
BMI (kg/m2) 27.7 6 4.0 25.0 6 2.7 ,0.001 27.4 6 5.0 23.5 6 3.9 ,0.001
Family history of
diabetes 36.8 15.9 ,0.001 49.6 22.1 ,0.001
Current smokers 11.8 7.3 ,0.001 29.5 20.8 ,0.001
Alcohol intake
(g/day) 11.2 6 16.2 12.1 6 15.3 0.18 4.4 6 9.1 6.6 6 10.0 ,0.001
Physical activity
(MET h/week) 14.6 6 19.0 21.1 6 25.2 ,0.001 11.7 6 15.3 14.3 6 18.7 ,0.001
Postmenopausal 35.0 31.3 0.01
Postmenopausal
hormone use 28.8 28.9 0.97
Low birth weight
(#2.5 kg) 6.8 5.7 0.39 12.1 9.7 0.06
Data are age-adjusted means 6 SD or % unless otherwise indicated.
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ﬁndings of other studies (12,19). A genetic
score based on 12 obesity-predisposing
common genetic variants was associated
with risk of incidence of type 2 diabetes
(12). In the current study, we updated the
obesity genotype score to included 32
SNPs and found similar results. Our pre-
vious study reported the joint effect of 10
diabetes-associated common genetic var-
iants on the development of type 2 diabe-
tes (19). In the current study, the
computation of the diabetes genotype
scores was expanded by inclusion of
25 newly identiﬁed loci. The updated
genotype scores represent broader char-
acteristics of genetic risk proﬁle and
account for more variation in disease risk.
Each additional BMI-increasing allele in
the obesity genotype score was associated
with a 3–4% (95% CI 1–6%) increased
odds of developing type 2 diabetes, while
each additional diabetes genotype score,
corresponding to one risk allele, was asso-
ciated with an 8–11% (4–13%) increased
odds of developing type 2 diabetes.
Intriguingly, we observed that the
overall genetic susceptibility to obesity
showed stronger associations with diabe-
tes risk among participants with low birth
weight than among those with high birth
weight. Two previous studies investigated
the interaction between birth weight and
genetic factors with regard to BMI. One
Table 2dAssociation between genotype scores and risk for type 2 diabetes in men and women
Continuous score
Quartile of score P
for trendQuartile 1 (lowest) Quartile 2 Quartile 3 Quartile 4 (highest)
Obesity genotype score
Men
n 561 596 612 653
Median (range) 24.7 (16.6–26.4) 27.8 (26.5–29.0) 30.3 (29.1–31.6) 33.5 (31.7–41.9)
Age adjusted 1.03 (1.01–1.05) 1.00 1.16 (0.92–1.47) 1.13 (0.90–1.42) 1.38 (1.10–1.73) 0.01
Multivariate adjusted* 1.03 (1.01–1.06) 1.00 1.21 (0.95–1.54) 1.16 (0.91–1.48) 1.44 (1.14–1.83) 0.006
Women
n 733 793 849 846
Median (range) 24.6 (14.8–26.4) 27.8 (26.5–29.0) 30.3 (29.1–31.9) 33.9 (32.0–43.3)
Age adjusted 1.03 (1.02–1.05) 1.00 1.23 (1.00–1.51) 1.36 (1.11–1.65) 1.41 (1.16–1.72) 0.0004
Multivariate adjusted* 1.04 (1.02–1.06) 1.00 1.15 (0.93–1.43) 1.28 (1.04–1.59) 1.41 (1.14–1.75) 0.0009
Diabetes genotype score
Men
n 491 551 634 746
Median (range) 32.6 (22.6–34.3) 35.8 (34.31–37.0) 38.3 (37.1–39.6) 41.8 (39.7–52.0)
Age adjusted 1.10 (1.08–1.12) 1.00 1.37 (1.07–1.77) 1.88 (1.47–2.39) 2.54 (2.00–3.21) ,0.0001
Multivariate adjusted* 1.11 (1.08–1.13) 1.00 1.43 (1.07–1.91) 1.88 (1.42–2.49) 2.76 (2.10–3.62) ,0.0001
Women
n 682 799 841 899
Median (range) 32.5 (23.9–34.3) 35.9 (34.32–37.0) 38.5 (37.1–39.9) 41.8 (39.9–51.2)
Age adjusted 1.06 (1.04–1.08) 1.00 1.50 (1.22–1.85) 1.66 (1.35–2.04) 1.91 (1.56–2.34) ,0.0001
Multivariate adjusted* 1.08 (1.05–1.10) 1.00 1.47 (1.15–1.88) 1.76 (1.38–2.25) 2.13 (1.67–2.70) ,0.0001
Data are OR (95% CI) unless otherwise indicated. *Adjusted for sex, age, family history of diabetes (yes or no), smoking (never, past, or current), alcohol intake
(0, 0.1–4.9, 5.0–9.9, 10.0–14.9, or $15.0 g/day), physical activity (quintiles), menopausal status (women only), and BMI (for diabetes gene scores only).
Table 3dAssociation between BMI and diabetes genotype scores and risk for type 2 diabetes according to birth weight in pooled
analysis of men and women
Birth weight (kg)
n
(case/control subjects)
Quartile of score P
for trendQuartile 1 (lowest) Quartile 2 Quartile 3 Quartile 4 (highest)
Obesity genotype score*
#2.5 174/169 1.00 1.23 (0.63–2.40) 2.06 (1.07–3.97) 2.55 (1.34–4.84) 0.002
.2.5 1,540/1,878 1.00 1.12 (0.91–1.37) 1.22 (1.00–1.48) 1.27 (1.04–1.55) 0.01
P for interaction 0.017
Diabetes genotype score*
#2.5 174/169 1.00 2.01 (0.93–4.32) 3.26 (1.47–7.22) 3.80 (1.76–8.24) 0.0006
.2.5 1,540/1,878 1.00 1.40 (1.11–1.76) 1.51 (1.20–1.89) 2.27 (1.82–2.83) ,0.0001
P for interaction 0.16
Data are multivariate-adjusted OR (95%CI) unless otherwise indicated. *Adjusted for sex, age, smoking (never, past, or current), alcohol intake (0, 0.1–4.9, 5.0–9.9,
10.0–14.9, or $15.0 g/day), physical activity (quintiles), menopausal status (women only), and BMI (for diabetes gene scores only).
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found that the effect of risk alleles of SNPs
in the FTO gene was more evident among
individuals with low birth weight than
among those with high birth weight
(30). The other study did not ﬁnd a signif-
icant interaction between birth weight
(low, medium, or high) and obesity geno-
type score (based on 24 SNPs) in predic-
tion of adult BMI in Danish subjects (P for
interaction = 0.07) (31). The birth weight–
gene interaction in relation to type 2 dia-
beteswas tested in one study based on nine
diabetes risk alleles, which showed that the
individuals with the lowest birth weight
and the most high-risk genotypes had the
greatest risk of type 2 diabetes (32). These
observations, including ours, suggest that
low birth weight may strengthen the dele-
terious effects of genetic variants on the
development of obesity or type 2 diabetes
in later life. As shown in the present study,
high obesity genetic susceptibility and
high diabetes genetic susceptibility were
jointly associated with a 72% increase in
the odds of developing type 2 diabetes in
individuals with high birth weight, while
among low–birth weight individuals, the
increase in the odds of developing type 2
diabetes was 370%.
The potential mechanisms underly-
ing the birth weight–gene interactions re-
main unclear. The fetal programming
hypothesis postulates that early life events
play a powerful role in inﬂuencing later
susceptibility to chronic diseases includ-
ing type 2 diabetes (1,2). Low birth
weight reﬂects intrauterine growth re-
striction, which may induce poor devel-
opment of pancreatic b-cell mass and
function (3), retarded skeletal muscle de-
velopment (33), changed set point of the
hypothalamic-pituitary-adrenal axis (34),
or epigenetic alterations such as DNA
methylation (35). These alterations may
subsequently affect insulin secretion or
insulin resistance. Of note, all these
changes may overlap with pathways link-
ing the genetic variations to the develop-
ment of type 2 diabetes (2), making the
interactions between low birth weight
and genetic factors possible. Our data in-
dicate that the obesity-associated genetic
variants, which are more closely related to
insulin resistance (9), are more likely
modulated by birth weight status than
the type 2 diabetes–associated genetic
variants, which are more tightly related
to insulin secretion (b-cell function).
A major strength of the current study
is our consistent ﬁndings from two well-
established large prospective cohorts. The
minimal population stratiﬁcation in our
study samples reduces the potential bias
due to heterogeneous genetic structure
(18). Several limitations deserve com-
ments. First, the genetic variants only
account for a small fraction of interindi-
vidual variation in BMI and diabetes risk.
Second, birth weight was not available for
one-third of participants in NHS and
HPFS. This may reduce our power to de-
tect the moderate interaction. Since char-
acteristics of the individuals with missing
birth weight were comparable to those
who reported birth weight, the missing
data are unlikely to artifactually affect
the associations (36).
In conclusion, our data suggest that
low birth weight and genetic susceptibil-
ity to obesity may synergistically affect
risk of type 2 diabetes in adulthood. Our
ﬁndings highlight the importance of more
extensive intervention in the low–birth
weight population, especially in those
with a high-risk genetic proﬁle, to reduce
diabetes risk in later life. Future studies
are warranted to investigate the potential
mechanisms and verify our ﬁndings, es-
pecially in other ethnicities.
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